Lipertance (Amlodipine Besilate, Perindopril Arginine, Atorvastatin Calcium Trihydrate)

Amlodipine blocks L‑type calcium channels, causing blood vessels to relax and lowering peripheral resistance. Perindopril inhibits the angiotensin‑converting enzyme, reducing angiotensin II formation and further decreasing blood pressure. Atorvastatin blocks HMG‑CoA reductase, the key enzyme in cholesterol synthesis, leading to lower LDL‑cholesterol and total cholesterol levels.

The appropriate dose of Lipertance is determined by the prescribing healthcare professional based on the patient’s clinical condition, response to therapy and any relevant laboratory values. Dosage may be adjusted over time, and patients should follow the exact regimen provided by their prescriber.

Lipertance is generally not recommended for use during pregnancy because the ACE‑inhibitor component (perindopril) can affect fetal development. Breastfeeding mothers should consult their physician, as the drug may be excreted in milk and could pose risks to the infant. Alternative therapies are usually considered.

To order Lipertance, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams across international markets. After the request, the sales team will verify trade or institutional credentials and respond with pricing, availability, shipping details and any necessary import documentation.

Lipertance combines a calcium‑channel blocker, an ACE inhibitor and a statin in a single tablet, offering a convenient triple‑therapy option. Compared with separate prescriptions, it reduces pill burden and may improve adherence. Some alternatives use a beta‑blocker or diuretic instead of amlodipine, but the overall efficacy in controlling blood pressure and cholesterol is comparable when doses are equivalent.

Store Lipertance at ambient temperature, preferably below 25 °C. Keep the tablets in the original blister pack or container, protect them from moisture, heat and direct sunlight. Do not store in the bathroom or near a kitchen sink, and keep out of reach of children.

Lipertance is taken orally, usually once daily, with or without food. Swallow the tablet whole with a glass of water. If a dose is missed, take it as soon as remembered unless it is near the time of the next scheduled dose; in that case, skip the missed dose and continue the regular schedule.

The most serious adverse events include angioedema (swelling of the face, lips, tongue or airway), severe liver injury (jaundice or marked enzyme elevation), myopathy or rhabdomyolysis (muscle pain with high creatine kinase), and hyperkalemia (elevated potassium). Patients should seek immediate medical attention if they experience any of these symptoms.

Lipertance should be avoided in patients with known hypersensitivity to any of its components, severe hepatic impairment, or in women who are pregnant. Caution is also advised for individuals with significant renal dysfunction, uncontrolled electrolyte disorders, or those taking contraindicated medications such as strong CYP3A4 inhibitors without appropriate monitoring.